Aromatase inhibitors versus tarnoxifen as adjuvant therapy for postmenopausal women with estrogen receptor positive breast cancer: meta-analyses of randomized trials of monotherapy... od Ingle, J, Dowsett, M, Cuzick, J, Davies, C

Sex-hormone status is related to rate of expansion of proximal femur diameter in women. od Kaptoge, S, Dalzell, N, Khaw, K, Beck, T, Loveridge, N, Dowsett, M, Reeve, J

A prospective study of endogenous serum hormone concentrations and breast cancer risk in premenopausal women on the island of Guernsey. od Thomas, H, Key, T, Allen, D, Moore, J, Dowsett, M, Fentiman, I, Wang, D

Re: Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. od Thomas, H, Key, T, Allen, D, Moore, J, Dowsett, M, Fentiman, I, Wang, D

A prospective study of endogenous serum hormone concentrations and breast cancer risk in post-menopausal women on the island of Guernsey. od Thomas, H, Key, T, Allen, D, Moore, J, Dowsett, M, Fentiman, I, Wang, D

Association between endogenous plasma hormone concentrations and fracture risk in men and women: the EPIC-Oxford prospective cohort study. od Roddam, A, Appleby, P, Neale, R, Dowsett, M, Folkerd, E, Tipper, S, Allen, N, Key, T

Aromatase Inhibitors Reduce the Expression of a Hypoxia Metagene in Oestrogen Receptor Positive Breast Cancer in Postmenopausal Women. od Ghazoui, Z, Buffa, F, Dunbier, A, Anderson, H, Dexter, T, Smith, I, Harris, A, Dowsett, M

Aromatase Inhibitors (AIs) Versus Not (Placebo/Observation) as Late Extended Adjuvant Therapy for Postmenopausal Women with Early Stage Breast Cancer (BC): Overviews of Randomized... od Goss, P, Mamounas, E, Jakesz, R, Markopoulos, C, Dowsett, M, Peto, R, Godwin, J, Davies, C

Microenvironmental Heterogeneity Parallels Breast Cancer Progression: A Histology-Genomic Integration Analysis od Natrajan, R, Sailem, H, Mardakheh, FK, Arias Garcia, M, Tape, CJ, Dowsett, M, Bakal, C, Yuan, Y

Close and stable relationship between proliferation and a hypoxia metagene in aromatase inhibitor-treated ER-positive breast cancer. od Ghazoui, Z, Buffa, F, Dunbier, A, Anderson, H, Dexter, T, Detre, S, Salter, J, Smith, I, Harris, A, Dowsett, M

Ki67 and breast cancer mortality in women with invasive breast cancer od Probert, J, Dodwell, D, Broggio, J, Charman, J, Dowsett, M, Kerr, A, McGale, P, Taylor, C, Darby, SC, Mannu, GS

Sex hormone status may modulate rate of expansion of proximal femur diameter in older women alongside other skeletal regulators. od Kaptoge, S, Dalzell, N, Folkerd, E, Doody, D, Khaw, K, Beck, T, Loveridge, N, Mawer, E, Berry, J, Shearer, M, Dowsett, M, Reeve, J

ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer. od Pinhel, I, Hills, M, Drury, S, Salter, J, Sumo, G, A'Hern, R, Bliss, J, Sestak, I, Cuzick, J, Barrett-Lee, P, Harris, A, Dowsett, M

20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years od Pan, H, Gray, R, Braybrooke, J, Davies, C, Taylor, C, McGale, P, Peto, R, Pritchard, K, Bergh, J, Dowsett, M, Hayes, D, Early Breast Cancer Trialists’ Collaborative Group

Synergistic activity of letrozole and sorafenib on breast cancer cells. od Bonelli, M, Fumarola, C, Alfieri, R, La Monica, S, Cavazzoni, A, Galetti, M, Gatti, R, Belletti, S, Harris, A, Fox, S, Evans, D, Dowsett, M, Martin, L, Bottini, A, Generali, D, Petronini, P

Meta-analysis of breast cancer outcomes in adjuvant trials of aromatase inhibitors versus tamoxifen od Dowsett, M, Cuzick, J, Ingle, J, Coates, A, Forbes, J, Bliss, J, Buyse, M, Baum, M, Buzdar, A, Colleoni, M, Coombes, C, Snowdon, C, Gnant, M, Jakesz, R, Kaufmann, M, Boccardo, F, Godwin, J, Davies, C, Peto, R

CYP3A variation, premenopausal estrone levels, and breast cancer risk. od Johnson, N, Walker, K, Gibson, L, Orr, N, Folkerd, E, Haynes, B, Palles, C, Coupland, B, Schoemaker, M, Jones, M, Broderick, P, Sawyer, E, Kerin, M, Tomlinson, I, Zvelebil, M, Chilcott-Burns, S, Tomczyk, K, Simpson, G, Williamson, J, Hillier, S, Ross, G, Houlston, R, Swerdlow, A, Ashworth, A, Dowsett, M

Circulating sex hormones and breast cancer risk factors in postmenopausal women: Reanalysis of 13 studies od Key, T, Appleby, P, Reeves, G, Roddam, A, Helzlsouer, K, Alberg, A, Rollison, D, Dorgan, J, Brinton, L, Overvad, K, Kaaks, R, Trichopoulou, A, Clavel-Chapelon, F, Panico, S, Duell, E, Peeters, P, Rinaldi, S, Fentiman, I, Dowsett, M, Manjer, J, Lenner, P, Hallmans, G, Baglietto, L, English, DR, Giles, G

Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. od Key, T, Appleby, P, Reeves, G, Roddam, A, Dorgan, J, Longcope, C, Stanczyk, F, Stephenson, H, Falk, RT, Miller, R, Schatzkin, A, Allen, D, Fentiman, I, Key, T, Wang, D, Dowsett, M, Thomas, H, Hankinson, SE, Toniolo, P, Akhmedkhanov, A, Koenig, K, Shore, R, Zeleniuch-Jacquotte, A, Berrino, F, Muti, P

Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. od Key, T, Appleby, P, Reeves, G, Roddam, A, Helzlsouer, K, Alberg, A, Rollison, D, Dorgan, J, Brinton, L, Overvad, K, Kaaks, R, Trichopoulou, A, Clavel-Chapelon, F, Panico, S, Duell, E, Peeters, P, Rinaldi, S, Fentiman, I, Dowsett, M, Manjer, J, Lenner, P, Hallmans, G, Baglietto, L, English, DR, Giles, G